What is 'Abbreviated New Drug Submission (ANDS)'

An Abbreviated New Drug Submission (ANDS) is a written request to Health Canada to obtain marketing approval for a generic drug. An Abbreviated New Drug Submission must be approved by Health Canada, the country’s federal department in charge of national health care, under Canada’s Food and Drug regulations, before the generic drug can be marketed in the country. An ANDS provides the necessary information for the government agency to evaluate how safe and effective a generic drug is compared with its brand-name equivalent. The generic must be equally safe and effective to gain approval.

BREAKING DOWN 'Abbreviated New Drug Submission (ANDS)'

An Abbreviated New Drug Submission is used to obtain approval for generic drugs. This is in contrast to a New Drug Submission (NDS), which is used to obtain approval for a new brand-name drug. An ANDS lists the related drug’s brand name, chemical name, manufacturer name, dosage form(s) and strength(s). It states whether the drug has already been approved for marketing in the United States, the European Union, Switzerland, Singapore and/or Australia. It also addresses questions about drug impurities and drug stability.

Generic drugs are biologically equivalent to the brand-name drugs on which they are based. They are comparable in dosage form, strength, route of administration, quality, performance characteristics and intended use. They are designated "abbreviated" because pre-clinical and clinical data is not required to establish their safety and efficacy.

An ANDS supplies information regarding data on studies comparing the proposed drug to the approved brand-name drug, called the “reference drug,” and asks for data from studies conducted on the generic drug. For example, for drugs with delivery devices, the ANDS states whether there have been studies comparing the physical and operating characteristics of the brand-name device with those of the proposed generic device. For tablets, it states whether the proposed generic drug has been scored like the brand name so the generic tablet can be divided similarly to the brand name tablet. The ANDS also supplies information about studies comparing the bioavailability of the brand name drug with that of the proposed generic drug, and about the results of bacterial endotoxin tests for sterile drugs. The applicant must pay a fee in conjunction with its ANDS.

ANDS and Biotechnology Investments

One way for investors to evaluate biotechnology companies is to examine their pipeline of ANDS. A company with a high number of pending ANDS relative to its competitors may end up with more generic drugs to sell and therefore be more profitable. 

  1. New Drug

    New drug is an original or innovative medication or therapy that ...
  2. New Drug Application (NDA)

    The New Drug Application (NDA) is the formal final step taken ...
  3. Food And Drug Administration - ...

    The Food and Drug Administration is a government agency that ...
  4. Bioavailability

    Bioavailability refers to the extent to which a dosage of a drug ...
  5. Side Effect

    Side effect is a negative or undesirable symptom or condition ...
  6. Healthcare Sector

    The healthcare sector consists of companies that provide medical ...
Related Articles
  1. Investing

    Market Vectors Launches First Generic Drugs ETF (GNRX)

    Generic drugs have been a growing market in recent years. Now there is an ETF targeted at this market.
  2. Investing

    Cost of Old Cancer Drugs Rises in EU Amid Outcry

    The prices of several off-patent cancer drugs have soared more than 100% in Europe.
  3. Insights

    How Pharmaceutical Companies Price Their Drugs

    Learn more about how pharmaceutical companies price drugs, why prices are often very high and why it can be difficult to settle on a suitable price.
  4. Insights

    Why Are Prescription Drug Prices So High?

    Expensive drugs that don’t have affordable alternatives or generic equivalents are a serious concern today. So why are prescription drug prices so high?
  5. Investing

    Pharma Balks at German Price Control (BAYRY, RHHBY)

    Drug makers are worried about a proposed new German law that would tighten price controls on prescription drugs.
  6. Investing

    Drug Prices: Name Brands Doubled in Last 5 Years (ESRX)

    Express Scripts' Drug Trends Report, released Monday, revealed that the average price of brand name drugs rose 16.2% in 2015, with over one third of brand name drugs seeing price increases over ...
  7. Investing

    Could the FDA Hiring Freeze Make Drugs More Expensive?

    Drug approvals by the resource-constrained FDA will take longer, leading to longer waits for the approval of cheaper alternatives.
  8. Investing

    It's No Accident That Drugs Are Expensive

    Branded drugs are expensive in large part because it's expensive and risky to develop them
  9. Investing

    Drug Makers May Face DOJ Lawsuit (LCI, ENDP)

    DOJ investigates more than a dozen generic drug companies over alleged price fixation for two-dozen drugs, based on two year long investigation
  10. Insurance

    How to Profit from the Generic Drug Trend

    Generic drugs are poised to steal market share as patent protections on a number of branded drugs expire. Investors should be ready, too.
  1. How does government regulation impact the drugs sector?

    Learn about how drugs are regulated by the U.S. government as well as the role of the Food and Drug Administration during ... Read Answer >>
  2. What are the major barriers to entry for new companies in the drugs sector?

    Find out why barriers to entry for U.S. drug companies are so high and how the Food and Drug Administration, or FDA, inhibits ... Read Answer >>
  3. Can your insurance company drug test you?

    Learn why drug companies conduct drug tests and how a lifestyle free of drugs and alcohol can save you big money on health ... Read Answer >>
  4. Who are Gilead Sciences' (GILD) main competitors?

    Learn about the pharmaceutical company Gilead Sciences and its main competitors. Explore the company's role in creating HIV-preventing ... Read Answer >>
  5. How does operating leverage affect business risk?

    Learn how operating leverage affects business risk and how companies measure it. Review a relevant example of operating leverage ... Read Answer >>
Hot Definitions
  1. Discount Rate

    Discount rate is the interest rate charged to commercial banks and other depository institutions for loans received from ...
  2. Economies of Scale

    Economies of scale refer to reduced costs per unit that arise from increased total output of a product. For example, a larger ...
  3. Quick Ratio

    The quick ratio measures a company’s ability to meet its short-term obligations with its most liquid assets.
  4. Leverage

    Leverage results from using borrowed capital as a source of funding when investing to expand the firm's asset base and generate ...
  5. Financial Risk

    Financial risk is the possibility that shareholders will lose money when investing in a company if its cash flow fails to ...
  6. Enterprise Value (EV)

    Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market ...
Trading Center